Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Blood

Volumn 124, Issue 13, 2014, Pages 2034-2045

  Khoder, Ahmad ^a   Sarvaria, Anushruti ^b   Alsuliman, Abdullah ^a   Chew, Claude ^b   Sekine, Takuya ^b   Cooper, Nichola ^a   Mielke, Stephan ^c   De Lavallade, Hugues ^a   Muftuoglu, Muharrem ^b   Curbelo, Irina Fernandez ^b   Liu, Enli ^b   Muraro, Paolo A ^a   Alousi, Amin ^b   Stringaris, Kate ^a   Parmar, Simrit ^b   Shah, Nina ^b   Shaim, Hila ^b   Yvon, Eric ^b   Molldrem, Jeffrey ^b   Rouce, Rayne ^d   Champlin, Richard ^b   McNiece, Ian ^b   Mauri, Claudia ^e   Shpall, Elizabeth J ^b   Rezvani, Katayoun ^b   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD19 ANTIGEN; CD24 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 10; METHOTREXATE; AUTACOID; CYTOKINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CONTACT; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DONOR; DONOR LYMPHOCYTE INFUSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; MOLECULAR PATHOLOGY; PRE B LYMPHOCYTE; REGULATORY B CELL; BIOSYNTHESIS; CASE CONTROL STUDY; CELL COMMUNICATION; CELL CULTURE; CHRONIC DISEASE; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; REGULATORY T LYMPHOCYTE;

ANTIGENS, CD19; ANTIGENS, CD24; ANTIGENS, CD27; ANTIGENS, CD38; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES, REGULATORY; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELLS, CULTURED; CHRONIC DISEASE; CYTOKINES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; IMMUNOMODULATION; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; T-LYMPHOCYTES, REGULATORY;

EID: 84907272636     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-04-571125     Document Type: Article

References (46)

1. Kalampokis I, Yoshizaki A, Tedder TF. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther. 2013; 15(Suppl 1):S1.
2. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006; 176(2):705-710.
3. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002; 16(2):219-230.
4. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002; 3(10): 944-950.
5. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003; 197(4):489-501.
6. Wei B, Velazquez P, Turovskaya O, et al. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci USA. 2005; 102(6): 2010-2015.
7. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012; 30:221-241.
8. Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol. 2010; 6(11):636-643.
9. Matsushita T, Tedder TF. Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. Methods Mol Biol. 2011; 677:99-111.
10. Blair PA, Noreña LY, Flores-Borja F, et al. CD19(1)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010; 32(1):129-140.
11. Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011; 117(2):530-541.
12. Li X, Zhong H, Bao W, et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood. 2012; 120(16): 3318-3325.
13. Saussine A, Tazi A, Feuillet S, et al. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS ONE. 2012; 7(8):e43588.
14. Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol. 2008; 64(2): 187-199.
15. Rezvani K, Mielke S, Ahmadzadeh M, et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 2006; 108(4):1291-1297.
16. Mielke S, Rezvani K, Savani BN, et al. Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood. 2007; 110(5): 1689-1697.
17. Zorn E, Kim HT, Lee SJ, et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood. 2005; 106(8):2903-2911.
18. Kapur R, Ebeling S, Hagenbeek A. B-cell involvement in chronic graft-versus-host disease. Haematologica. 2008; 93(11):1702-1711.
19. Allen JL, Fore MS, Wooten J, et al. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. Blood. 2012; 120(12):2529-2536.
20. Sanz I, Wei C, Lee FE, Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol. 2008; 20(1):67-82.
21. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 2000; 67(1):2-17.
22. Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in man that parallels mouse regulatory B10 cells. Blood. 2011; 117(2):530-541.
23. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005; 11(12):945-956.
24. Atkinson K. Clinical Bone Marrow and Blood Stem Cell Transplantation. New York, NY: Cambridge University Press; 2003.
25. Corre E, Carmagnat M, Busson M, et al. Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections. Haematologica. 2010; 95(6):1025-1029.
26. Sarantopoulos S, Stevenson KE, Kim HT, et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood. 2009; 113(16):3865-3874.
27. Hilgendorf I, Mueller-Hilke B, Kundt G, et al. The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection. Transpl Int. 2012; 25(1):87-96.
28. Yamashita K, Choi U, Woltz PC, et al. Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells. Blood. 2004; 103(10):3986-3988.
29. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980; 69(2): 204-217.
30. Bouaziz JD, Calbo S, Maho-Vaillant M, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010; 40(10):2686-2691.
31. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008; 28(5):639-650.
32. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol. 2009; 182(12): 7459-7472.
33. Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA. 2007; 104(35): 14080-14085.
34. Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007; 178(12):7868-7878.
35. Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol. 2009; 182(6):3492-3502.
36. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev. 2003; 55(2):241-269.
37. Goerner M, Gooley T, Flowers ME, et al. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant. 2002; 8(1):47-56.
38. Le Huu D, Matsushita T, Jin G, et al. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood. 2013; 121(16): 3274-3283.
39. Weber M, Stein P, Prüfer S, et al. Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease. Eur J Immunol. 2014; 44(6):1857-1865.
40. Barak V, Levi-Schaffer F, Nisman B, Nagler A. Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma. 1995; 17(1-2): 169-173.
41. Liem LM, Fibbe WE, van Houwelingen HC, Goulmy E. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation. 1999; 67(1): 59-65.
42. Körholz D, Kunst D, Hempel L, et al. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997; 19(7):691-695.
43. Wykes M. Why do B cells produce CD40 ligand? Immunol Cell Biol. 2003; 81(4):328-331.
44. Sarantopoulos S, Stevenson KE, Kim HT, et al. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. Blood. 2011; 117(7):2275-2283.
45. Kuzmina Z, Greinix HT, Weigl R, et al. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. Blood. 2011; 117(7):2265-2274.
46. Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006; 108(2):756-762.